Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
- PMID: 33001206
- PMCID: PMC7714093
- DOI: 10.1182/blood.2020008367
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
Abstract
There is a
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures


Comment in
-
Catch those antibodies before they fall.Blood. 2020 Nov 26;136(22):2489-2490. doi: 10.1182/blood.2020008768. Blood. 2020. PMID: 33242330 Free PMC article.
Similar articles
-
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.J Infect Dis. 2021 Oct 28;224(8):1294-1304. doi: 10.1093/infdis/jiab295. J Infect Dis. 2021. PMID: 34089610 Free PMC article.
-
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22. Microbiol Spectr. 2021. PMID: 34550000 Free PMC article.
-
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.Front Immunol. 2022 Jan 27;13:829665. doi: 10.3389/fimmu.2022.829665. eCollection 2022. Front Immunol. 2022. PMID: 35154152 Free PMC article.
-
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.mSphere. 2021 Aug 25;6(4):e0027521. doi: 10.1128/mSphere.00275-21. Epub 2021 Aug 25. mSphere. 2021. PMID: 34431693 Free PMC article.
-
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy.Commun Biol. 2021 Feb 24;4(1):267. doi: 10.1038/s42003-021-01813-y. Commun Biol. 2021. PMID: 33627795 Free PMC article.
Cited by
-
Frequency of SARS-CoV-2 Infections among Healthcare Workers in Germany: 3-Year Follow-Up Study.Infect Dis Rep. 2024 Jul 19;16(4):615-627. doi: 10.3390/idr16040047. Infect Dis Rep. 2024. PMID: 39051247 Free PMC article.
-
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.Eur J Intern Med. 2021 Jul;89:87-96. doi: 10.1016/j.ejim.2021.05.010. Epub 2021 May 18. Eur J Intern Med. 2021. PMID: 34053848 Free PMC article. Clinical Trial.
-
Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.Infect Dis (Lond). 2021 Jul;53(7):498-512. doi: 10.1080/23744235.2021.1893378. Epub 2021 Mar 8. Infect Dis (Lond). 2021. PMID: 33684020 Free PMC article.
-
Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies who recovered from SARS-COV-2 infection.Hematol Oncol. 2021 Aug;39(3):428-431. doi: 10.1002/hon.2872. Epub 2021 May 5. Hematol Oncol. 2021. PMID: 33951220 Free PMC article. No abstract available.
-
First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile.J Environ Public Health. 2022 Apr 27;2022:3859071. doi: 10.1155/2022/3859071. eCollection 2022. J Environ Public Health. 2022. PMID: 35528635 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous